Akebia Therapeutics, Inc. (AKBA)
NASDAQ·Healthcare·Biotechnology
$1.04
+5.18%
Mkt Cap $251.81M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+286.5%
Consensus $4.00 vs current $1.04
NASDAQ·Healthcare·Biotechnology
$1.04
+5.18%
Mkt Cap $251.81M
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$4.00
Range $4.00 – $4.00
+286.5%
Consensus $4.00 vs current $1.04